Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation

Liver Transpl. 2006 May;12(5):827-30. doi: 10.1002/lt.20706.

Abstract

A 55-year-old Caucasian male developed a well characterized autoimmune hepatitis after completing treatment with pegylated interferon and ribavirin for recurrent hepatitis C. We hypothesize that pegylated interferon triggered a severe form of immune-mediated hepatitis.

Publication types

  • Case Reports

MeSH terms

  • Antiviral Agents / adverse effects*
  • Hepatitis C / complications
  • Hepatitis C / drug therapy*
  • Hepatitis, Autoimmune / etiology*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / adverse effects*
  • Liver Cirrhosis / surgery
  • Liver Transplantation / adverse effects*
  • Male
  • Middle Aged
  • Polyethylene Glycols / adverse effects*
  • Recombinant Proteins

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • peginterferon alfa-2a